Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004770

President sold 30,000 shares at an average $68.66 ($2,059,796)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-19 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-19 Sale : show line 2 in the form −2,563 $68.72 $176,129 12,437 D
2021-01-19 Sale : show line 3 in the form −7,415 $69.54 $515,639 5,022 D
2021-01-19 Sale : show line 4 in the form −4,822 $70.51 $339,999 200 D
2021-01-19 Sale : show line 5 in the form −200 $71.23 $14,246 0 D
2021-01-20 Exercise or conversion : show line 6 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-20 Sale : show line 7 in the form −4,366 $66.49 $290,295 10,634 D
2021-01-20 Sale : show line 8 in the form −4,264 $67.58 $288,161 6,370 D
2021-01-20 Sale : show line 9 in the form −6,370 $68.34 $435,326 0 D
Open-market sales · 30,000 sh · avg $68.66 · $2,059,796

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-19 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −15,000 215,000 D
2021-01-20 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −15,000 200,000 D
Loading xslF345X03/doc4.xml…